Polymorphisms in glutathione S-transferase are risk factors for perioperative acute myocardial infarction after cardiac surgery: A preliminary study

Molecular and Cellular Biochemistry

Volumn 389, Issue 1-2, 2014, Pages 79-84

  Kovacs, Viktória ^a   Gasz, Balazs ^b   Balatonyi, Borbala ^a   Jaromi, Luca ^a   Kisfali, Peter ^a   Borsiczky, Balazs ^a   Jancso, Gabor ^a   Marczin, Nandor ^c   Szabados, Sandor ^a   Melegh, Bela ^a   Nasri, Alotti ^b   Roth, Elisabeth ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Zala County Hospital   (Hungary)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac surgery; Gene polymorphism; Glutathione S transferase P1; Perioperative acute myocardial infarction

Indexed keywords

GLUTATHIONE TRANSFERASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEART MUSCLE INJURY; HEART SURGERY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPEN HEART SURGERY; OXIDATIVE STRESS; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84896543444     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1929-7     Document Type: Article

References (43)

1. Yau JM, Alexander JH, Hafley G et al (2008) Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from project of ex-vivo vein graft engineering via transfection (PREVENT) IV). Am J Cardiol 102:546-551
2. Mangano DT (1997) Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The multicenter study of perioperative ischemia (McSPI) research group. JAMA 277:325-332
3. Nalysnyk L, Fahrbach K, Reynolds MW (2003) Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 89:767-772 (Pubitemid 36760639)
4. Thielmann M, Massoudy P, Schmermund A et al (2005) Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 26:2440-2447 (Pubitemid 41552974)
5. Mohammed AA, Agnihotri AK, van Kimmenade RR et al (2009) Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation 120:843-850
6. Alexander JH, Hafley G, Harrington RA et al (2005) Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294:2446-2454 (Pubitemid 41627922)
7. Podgoreanu MV, White WD, Morris RW et al (2006) Perioperative genetics and safety outcomes study (PEGASUS) Investigative team. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 114:275-281
8. Liu Kuang-Yu, Muehlschlegel Jochen D, Perry Tjörvi E et al (2010) Common genetic variants on chromosome 9p21 predict perioperative myocardial injury after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 139:483-488
9. Roth E, Hejjel L (2003) Oxygen free radicals in heart disease. In: Pugsley MK (ed) Cardiac Drug Development Guide. Humana Press, New jersy, pp 47-66
10. Elahi MM, Khan JS, Matata BM (2006) Deleterious effects of cardiopulmonary bypass in coronary artery surgery and scientific interpretation of off-pump's logic. Acute Card Care 8:196-209 (Pubitemid 44950061)
11. Butler J, Rocker GM, Westaby S (1993) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:552-559 (Pubitemid 23060844)
12. Hall RI, Smith MS, Rocker G (1997) The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85:766-782 (Pubitemid 27418878)
13. Wan S, LeClerc JL, Vincent JL (1997) Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112:676-692 (Pubitemid 27410703)
14. Sharma R, Gupta S, Singhal SS, Ahmad H, Haque A, Awasthi YC (1991) Independent segregation of glutathione S-transferase and fatty acid ethyl ester synthase from pancreas and other human tissues. Biochem J 275:507-513
15. Ali-Osman F, Akande O, Antoun G et al (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants: evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272:10004-10012 (Pubitemid 27171673)
16. Volzke H, Engel J, Kleine V et al (2002) Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest 122:31-36 (Pubitemid 34754139)
17. Fox Amanda A, Collard Charles D, Shernan Stanton K et al (2009) Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting. Anesthesiology 110:738-747
18. Emiroglu Ozan, Durdu Serkan, Egin Yonca et al (2011) Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery. J Cardiothorac Surg 6:120
19. Tekeli A, Isbir S, Ergen A et al (2008) APE1 and XRCC3 polymorphisms and myocardial infarction. In Vivo 22:477-479
20. Lobato RL, White WD, Mathew JP et al (2011) Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. Circulation 124:S143-S148
21. Eifert S, Rasch A, Beiras-Fernandez A et al (2009) Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG. J Cardiothorac Surg 4:46
22. Frey UH, Kottenberg E, Kamler M et al (2011) Genetic interactions in the b-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: a pilot study. Br J Anaesth 107:869-878
23. Stȩpień E, Krawczyk S, Kapelak B et al (2011) Effect of the E-selectin gene polymorphism (S149R) on platelet activation and adverse events after coronary artery surgery. Arch Med Res 42:375-381
24. Muehlschlegel JD, Liu KY, Perry TE et al (2010) Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation 122:S60-S65
25. Virani SS, Brautbar A, Lee VV et al (2012) Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J 76:950-956
26. Isbir S, Ergen A, Yilmaz H et al (2008) Effect of Ala16Val genetic polymorphism of MnSOD on antioxidant capacity and inflammatory response in open heart surgery. In Vivo 22:147-151
27. Kornblit B, Munthe-Fog L, Madsen HO et al (2008) Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care 12:R83
28. Wypasek E, Stepien E, Kot M et al (2012) Fibrinogen beta-chain-C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting. Inflammation 35:429-435
29. Perry TE, Muehlschlegel JD, Liu KY et al (2009) C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. BMC Med Genet 10:38
30. Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a co- ordinately regulated defence against oxidative stress. Free Radical Res 31:273-300 (Pubitemid 29452854)
31. Suvakov S, Damjanovic T, Stefanovic A et al (2013) Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. Nephrol Dial Transplant 28:202-212
32. McIlwain CC, Townsend DM, Tew KD (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:1639-1648
33. Ruscoe JE, Rosario LA, Wang T et al (2001) Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferaton pathways. J Pharmacol Exp Ther 298:339-345 (Pubitemid 32574545)
34. Christie JD, Aplenc R, DeAdrade J et al (2005) Donor glutathione S-transferase genotype is assotiated with primary graft dysfunction following lung transplantation. J Heart Lung Transplant 24:S80
35. Hadjiliadis D, Lingaraju R, Mendez J et al (2007) Donor glutathione S-transferase (GST) mu null genotype in lung transplant recipients is assotiated with increased incidence of bronchiolitis obliterans (BOS) independent of acute rejection. J Heart Lung Transplant 26:S108
36. Cora T, Tokac M, Acar H et al (2013) Glutathione S-transferase M1 and T1 genotypes and myocardial infarction. Mol Biol Rep 40:3263-3267
37. Wilson MH, Grant PJ, Kain K et al (2003) Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers 8:43-50 (Pubitemid 36104167)
38. Wilson MH, Grant PJ, Hardie LJ et al (2000) Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J 14:791-796 (Pubitemid 30198577)
39. Nomani H, Mozafari H, Ghobadloo SM et al (2011) The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran. Mol Cell Biochem 354:181-187
40. Moscow JA, Fairchild CR, Madden MJ et al (1989) Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422-1428 (Pubitemid 19088676)
41. Allan JM, Wild CP, Rollinson S et al (2001) Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 98:11592-11597 (Pubitemid 32928773)
42. Tuna G, Kulaksiz Erkmen G, Dalmizrak O et al (2010) Inhibition characteristics of hypericin on rat small intestine glutathione-S-transferases. Chem Biol Interact: 18859-18865
43. Henderson CJ, Wolf CR, Kitteringham N et al (2000) Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci USA 97:12741-12745